SCHEMBL10011527

SCHEMBL10011527

COC(=O)CCC(O[Si](C)(C)C)C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.43
SLC1A1 P43005 1/20 0.38
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
CA12 O43570 3/20 0.33
LMNA P02545 2/20 0.33
CA14 Q9ULX7 2/20 0.33
ALOX5 P09917 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
HSD17B10 Q99714 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10012427 0.81 TSHR (0.36) TSHRKMT2AHSD17B10ALDH1A1MGAM
SCHEMBL10012535 0.80 TSHR (0.50) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL1155342 0.78 TSHR (0.33) TSHRSLC1A1
SCHEMBL10010463 0.77 TSHR (0.46) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL10010645 0.76 TSHR (0.44) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL10010940 0.74 TSHR (0.43) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL17055793 0.74 TSHR (0.52) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL4057765 0.74 TSHR (0.52) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL14436811 0.74 TSHR (0.52) TSHRSLC1A1KMT2AMEN1CA12
SCHEMBL29578044 0.74 TSHR (0.35) TSHRSLC1A1CA12CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 TSHR 3669/4885SLC1A1 238/4885KMT2A 3003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.